Application no. and date | 18187681.4 (espacenet) (Federated) (European Patent Register), 20070212 | Patent/reg. no. and date | DK/EP 3438131, 20220316 | Publication date | 20190206 | Priority no. and date | US 772221 P, 20060210, US 804640 P, 20060613 | EP pub. no. and date |
EP 3438131 20190206 | Effective date | | Applicant/owner | Life Technologies Corporation, 5823 Newton Drive
Carlsbad, CA 92008, US | Applicant ref. no. | BBS186966EPDK | Inventor | AGNEW, Brian, 2520 W. 23rd Ave
Eugene, OR 97405, US, GEE, Kyle R., 37699 Upper Camp Creek Road
Springfield, OR 97478, US, CORRY, Schuyler B., 3655 Westleigh St
Eugene, OR 97405, US | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | Opponent | | IPC Class | A61K 47/54 (2017.01) , C07K 1/13 (2006.01) , C12P 21/00 (2006.01) , G01N 33/531 (2006.01) , G01N 33/532 (2006.01) | Title | OLIGOSACCHARIDMODIFIKATION OG MÆRKNING AF PROTEINER | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|